NCT02869074View on ClinicalTrials.gov

Molecular and Clinical Profile of Von Willebrand Disease in Spain

CompletedOBSERVATIONAL
Enrollment

790

Participants

Timeline

Start Date

October 3, 2017

Primary Completion Date

September 25, 2021

Study Completion Date

September 25, 2021

Conditions
Von Willebrand Disease
Interventions
GENETIC

VWF gene analysis

52 exons adjacent intronic regions and promotor of VWF will be analyzed

Trial Locations (1)

33011

Hospital Universitario Central de Asturias, Oviedo

All Listed Sponsors
collaborator

Francisco Vidal Pérez

UNKNOWN

collaborator

Maria Fernanda López Fernández

UNKNOWN

collaborator

Almudena Pérez Rodríguez

UNKNOWN

collaborator

Irene Corrales Insa

UNKNOWN

collaborator

Ana Rosa Cid Haro

UNKNOWN

lead

Spanish Society of Thrombosis and Haemostasis

OTHER

NCT02869074 - Molecular and Clinical Profile of Von Willebrand Disease in Spain | Biotech Hunter | Biotech Hunter